Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Assessment of QT Interval Prolongation Using Concentration-QT Modeling for Iptacopan, an Oral Complement Factor B Inhibitor, in Healthy Individuals.
Journal: Clinical and translational science
Published: March 25, 2025
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants.
Journal: Clinical and translational science
Published: February 15, 2024
Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants.
Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: February 08, 2024
Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug-Drug Interaction of Avacopan in 2 Open-Label Studies in Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: October 02, 2023
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 19, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants.
Journal: JACC. Basic to translational science
Published: January 06, 2022
Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
Journal: Pharmacology research & perspectives
Published: June 01, 2021
Lack of a Clinically Meaningful Drug Interaction Between the HIV-1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate.
Journal: Clinical pharmacology in drug development
Published: December 10, 2020
Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer.
Journal: Clinical pharmacokinetics
Published: April 28, 2020
Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.
Journal: Journal of clinical pharmacology
Published: November 22, 2019
First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults.
Journal: Antimicrobial agents and chemotherapy
Published: May 11, 2019
A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Journal: Advances in therapy
Published: November 15, 2017
Last Updated: 09/26/2026